Saltar al contenido
Merck
  • Mixed-ligand Cu(II)-vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity.

Mixed-ligand Cu(II)-vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity.

European journal of medicinal chemistry (2013-01-08)
Sartaj Tabassum, Samira Amir, Farukh Arjmand, Claudio Pettinari, Fabio Marchetti, Norberto Masciocchi, Giulio Lupidi, Riccardo Pettinari
RESUMEN

SOD mimics with varying coligand are momentous in developing potential chemotherapeutic drugs. Cu(II) based SOD mimics 1-4 [CuLH(OAc)(H(2)O)Y)] (LH = 2-((E)-(1,3-dihydroxy-2-methylpropan-2-ylimino)methyl)-6-methoxyphenol, OAc = CH(3)COO, 1: Y = H(2)O; 2: Y = phen (1,10-phenanthroline), 3: Y = tpimH (2,4,5-triphenylimidazole); 4: Y = tfbimH (2-(trifluoromethyl)benzimidazole) were synthesized and thoroughly characterized. Their interaction with CT-DNA showed different non-covalent binding behaviour. SOD activity of 2 was highest among 1-4 which was further validated by gel electrophoresis. The pBR322 plasmid strand break offered by 2 + O₂·⁻ system reveals oxidative cleavage mechanism. In vitro antimicrobial activity of 1-4 was shown by percent inhibition data while in vitro anticancer activity of 1-4 was screened using 16 human carcinoma cell lines of different histological origin. Complex 2 showed higher efficacy towards 14 cell lines.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Vainillina, ReagentPlus®, 99%
Supelco
Vainillina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Vainillina, natural, ≥97%, FCC, FG
Sigma-Aldrich
Vainillina, ≥97%, FCC, FG
Supelco
Vainillina, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Vainillina, traceable to primary standards (LGC)
Sigma-Aldrich
Vainillina, tested according to Ph. Eur.
Vainillina, European Pharmacopoeia (EP) Reference Standard